Product image of Idhifa 50 mg (Enasidenib) 50 MG Tablet supplied by GNH India

Idhifa 50 mg

Active Ingredient:
Enasidenib
Form:
Tablet
Brand:
IDHIFA
Origin:
USA

Idhifa 50 mg (Enasidenib Tablet) 50 MG

IDHIFA 50 MG (enasidenib) is a prescription tablet used in cancer therapy. This oral medication targets specific mutations for targeted treatment. Suitable for patients requiring precision oncology solutions. Keep out of reach of children.

Strength

50 MG

Pack Size

30s

Storage

15-25°

Manufacturer / TM Owner

Bristol-Myers Squibb Company

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • IDHIFA 50 MG is prescribed for the treatment of certain types of acute myeloid leukemia (AML) in adults. It is specifically used for patients with a specific genetic mutation (IDH2). This medication helps slow the progression of cancer cells by targeting the mutation. Patients should consult their healthcare provider to confirm suitability.

Side Effects

  • IDHIFA 50 MG works by interfering with the abnormal proteins produced by the IDH2 mutation. This may help reduce symptoms associated with AML, such as fatigue or frequent infections. Some patients may experience improved blood cell counts over time. Individual responses vary based on medical history.

Precautions & Warnings

  • Store IDHIFA 50 MG tablets at room temperature between 15–25°C. Keep the medication in its original container, tightly closed, and away from moisture or heat. Do not use if the packaging is damaged or the tablets appear altered. Always follow your doctor’s storage instructions.

Avoid Interactions

  • IDHIFA 50 MG may interact with other medications, including certain antibiotics, antifungals, or herbal supplements. Avoid grapefruit products as they can affect how the drug is processed. Inform your healthcare provider about all prescription, over-the-counter, and herbal products you are using. Regular monitoring may be required.

Frequently Asked Questions

IDHIFA 50 MG is used to treat acute myeloid leukemia (AML) in adults with a specific genetic mutation (IDH2).

Store at room temperature (15–25°C) in the original container, away from moisture and heat.

Consult your doctor before combining with other drugs, as interactions may occur. Avoid grapefruit products.

Take the missed dose as soon as you remember, unless it’s close to the next scheduled dose. Skip the missed dose if it’s almost time for the next one.

Common effects may include nausea, fatigue, or changes in blood cell counts. Report persistent symptoms to your healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Enasidenib

Enasidenib 100mg

Enasidenib 100mg

100mg Tablet
Idhifa

Idhifa

100mg Tablet
IDHIFA 100mg

IDHIFA 100mg

100mg Tablet

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT